This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest

Case Study – Unidose Nasal Spray Pump in Hypoglycemia
Case Studies, Pharmaceutical, Market Insights, Product Solutions, Drug Delivery Innovations

Case Study – Unidose Nasal Spray Pump for Opioid Overdose
Case Studies, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions

Spray Dried Formulations for Nasal Applications – Challenges and Opportunities in F...
Publications, Pharmaceutical, Product Solutions, Drug Delivery Innovations

Development of In Vitro Nasal Cast Imaging Techniques to Predict In Vivo Nasal Deposi...
Publications, Pharmaceutical, Drug Delivery Innovations, Product Solutions